CLINICAL_TRIALS
trial_result
· 2024-11-29
Clinical Trial Update: GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study
Summary
This update reports the completion of the post-marketing surveillance study for the GORE VIABAHN Endoprosthesis, with results posted on 2024-11-29.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: W.L.Gore & Associates | Conditions: Vascular Stent-Graft Stenosis | Status: COMPLETED | Results posted: 2024-11-29